期刊文献+

Smad7对肝癌细胞增殖和迁移的影响及其临床意义 被引量:2

The Role of Smad7 in Hepatocellular Carcinoma Proliferation and Migration and Its Clinical Significance
原文传递
导出
摘要 目的:探究Smad7对肝癌细胞增殖和迁移的影响及其临床意义。方法:通过转染pcDNA3.1(+)-Smad7质粒或Smad7的小干扰RNA使得Smad7在肝癌细胞系HepG2和Huh7中过表达或敲减,应用MTT法检测Smad7对肝癌细胞增殖的影响,采用细胞划痕实验以及Transwell实验探讨Smad7对肝癌细胞迁移的影响。采用qRT-PCR检测9例肝癌癌患者手术切除的组织样本中Smad7的表达。结果:过表达Smad7的肝癌细胞增殖能力与对照组相比有明显的下降,而敲减smad7能够促进肝癌细胞的增殖。过表达smad7的肝癌细胞穿过Transwell小室底膜的能力显著下降,而敲减Smad7能够促进这种能力。Smad7在肝癌癌旁组织中的表达显著高于癌组织。结论:Smad7能够在肝细胞肝癌的进展中发挥负向调控作用。 Objective: To investigate the role of Smad7 in the Hepatocellular carcinoma (HCC) migration and proliferation and its clinical significance. Methods: Through transfecting pcDNA3.1 (+)-Smad7 or siRNA Smad7 to overexpress or knockdown the Smad7 expression in HCC cell lines HepG2 and Huh7. The MTT assays were used to test the role of Smad7 in proliferation of HCC cells. Transwell and wound-healing assays were used to detect the effect of Smad7 on migratory ability in both tow cell lines. RT-PCR was used to test the Smad7 expression in 9 clinical HCC patients' specimens. Results: As the results, overexpression of Smad7 significantly inhibited the proliferation of cells compared with the control group, while knockdown Smad7 promoted the proliferation. At the same time, overexpression of Smad7 could inhibit the migratory ability of HCC cells compared with the control group, while knockdown smad7 could accelerate this ability. The expression of Smad7 in cancer tissue was significantly lower compared with normal mucosa tissue adjacent to cancer. Conclusions: Smad7 is a kind of anti-progressive molecule in HCC.
出处 《现代生物医学进展》 CAS 2017年第23期4437-4440,4461,共5页 Progress in Modern Biomedicine
基金 江苏省卫生厅医学科研项目(Q201401) 苏州市科技发展项目(SYSD2015078)
关键词 肝细胞肝癌 SMAD7 增殖 迁移 负向调控作用 Hepatocellular carcinoma Smad7 Proliferation Migration Negative regulation
  • 相关文献

参考文献4

二级参考文献32

  • 1申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:398
  • 2罗运权,吴孟超,陈汉,钱光相,张晓华.大鼠肝脏癌变过程中肝细胞生长因子及其受体基因表达的研究[J].中华医学杂志,1996,76(11):822-825. 被引量:22
  • 3Llovet JM, Burroughs A, Briix J. Hepatocellular carcinoma [J]. Lancet, 2003, 362 (9399): 1907-17.
  • 4Bomstein S, Hoot K, Han GW, et al. Distinct roles of individual Smads in skin carcinogenesis [J].Mol Carcinog, 2007, 46(8): 660-4.
  • 5Saunier EF, Akhurst RJ. TGF beta inhibition for cancer therapy [J]. Curr Cancer Drug Targets, 2006, 6(7): 565-78.
  • 6Bedossa P, Peltier E, Terris B, et al. Transforming growth factor beta 1 (TGF beta 1 )and TGF beta 1 receptors in normal, cirrhotic,and neoplastic human livers [J ]. Hepatology, 1995, 21 (3): 760-5.
  • 7Subramanian G, Schwarz RE, Higgins L, et al. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype [J]. Cancer Res, 2004, 64( 15): 5200-11.
  • 8Korchynskyi O, Landstrom M, Stoika R, et al. Expression of Smad proteins in human colorectal cancer[J].Int J Cancer, 1999, 82(2): 197-202.
  • 9Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA: a cancer journal for clinicians, 2011, 61(2): 69-90.
  • 10Inui M, MarteUo G, Piccolo S. MicroRNA control of signal transduction [J]. Nature reviews Molecular cell biology, 2010, 11(4): 252-263.

共引文献49

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部